Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Splinter

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
British Journal of Cancer|December 4, 2003
Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapyM B Polee, W C J Hop, T C Kok, et al.
Journal of the National Cancer Institute|March 22, 2007
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancerJan P van Meerbeeck, Gijs W P M Kramer, Paul E Y Van Schil, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer GroupM S Aapro, F H van Wijk, M E L van der Burg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer GroupF H van Wijk, M S Aapro, G Bolis, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
British Journal of Cancer|December 4, 2003
Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapyM B Polee, W C J Hop, T C Kok, et al.
Journal of the National Cancer Institute|March 22, 2007
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancerJan P van Meerbeeck, Gijs W P M Kramer, Paul E Y Van Schil, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer GroupM S Aapro, F H van Wijk, M E L van der Burg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer GroupF H van Wijk, M S Aapro, G Bolis, et al.
Pageof 3